|
1
|
Kundi M, Obermeier P, Helfert S, Oubari H,
Fitzinger S, Yun JA, Brix M and Rath B: The impact of the
parent-physician relationship on parental vaccine safety
perceptions. Curr Drug Saf. 10:16–22. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holt D, Bouder F, Elemuwa C, Gaedicke G,
Khamesipour A, Kisler B, Kochhar S, Kutalek R, Maurer W, Obermeier
P, et al: The importance of the patient voice in vaccine safety and
immunization - are we listening? ESCMID. 22 (Suppl 5):S146–153.
2016.
|
|
3
|
Bouder F: Benefit/risk communication by
the European Medicines Agency: a study of influential stakeholders'
expectations and attitudes 2011European Medicines Agency (EMA);
London: 2011, https://www.ema.europa.eu/en/documents/report/benefit/risk-communication-european-medicines-agency-study-influential-stakeholders-expectations-attitudes_en.pdfMay
202019
|
|
4
|
Ma X, Alchikh M, Conrad T, et al: Can we
Distinguish Respiratory Viral Infections based on Clinical
Symptoms? Lessons from a Pediatric Inception CohortProceedings of
the ASM2017 Microbe - American Society for Microbiology Conference.
New Orleans, LA: 2017
|
|
5
|
Alchikh M, Conrad T, Hoppe C, Broberg E,
Penttinen P, Reiche J, Biere B, Schweiger B and Rath B: Are we
missing respiratory viral infections in infants and children?
Comparison of a hospital-based quality management system with
standard of care. ESCMID. 25:380.e9–.380.e16. 2019.
|
|
6
|
Rath B, Tief F, Karsch K, Muehlhans S,
Obermeier P, Adamou E, Chen X, Seeber L, Peiser C, Hoppe C, et al:
Towards a personalised approach to managing influenza infections in
infants and children - food for thought and a note on oseltamivir.
Infect Disord Drug Targets. 13:25–33. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tuttle R, Weick A, Schwarz WS, Chen X,
Obermeier P, Seeber L, Tief F, Muehlhans S, Karsch K, Peiser C, et
al: Evaluation of novel second-generation RSV and influenza rapid
tests at the point of care. Diagn Microbiol Infect Dis. 81:171–176.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rath B, Tief F, Obermeier P, Tuerk E,
Karsch K, Muehlhans S, Adamou E, Duwe S and Schweiger B: Early
detection of influenza A and B infection in infants and children
using conventional and fluorescence-based rapid testing. J Clin
Virol. 55:329–333. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen X, Pouran Yousef K, Duwe S, Karsch K,
Grover S, Wählisch S, Obermeier P, Tief F, Mühlhans S, Seeber L, et
al: Quantitative influenza follow-up testing (QIFT) - a novel
biomarker for the monitoring of disease activity at the
point-of-care. PLoS One. 9:e925002014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
CDRH Microbiology Devices Advisory
Committee Meeting. Executive Summary, . Proposed reclassification
of the rapid influenza detection tests. Food and Drug
Administration, Gaithersburg, MD. 2013, http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/MicrobiologyDevicesPanel/UCM356185.pdfSeptember
28–2013
|
|
11
|
Rath B, Blumentals W, Miller K, Starzyk K,
Tetiurka B and Wollenhaupt M: A prospective observational study of
oseltamivir safety and tolerability in infants and young children
≤24 months. Pharmacoepidemiol Drug Saf. 24:286–296, 215. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rath B, Brzostek J, Guillén S, Niranjan V,
Chappey C, Rayner C and Clinch B: Safety, virology and
pharmacokinetics of oseltamivir in infants with
laboratory-confirmed influenza infection: A Phase I/II,
prospective, open-label, multi-center clinical trial. Antivi Ther.
20:815–825. 2015. View
Article : Google Scholar
|
|
13
|
Kamal MA, Acosta EP, Kimberlin DW,
Gibiansky L, Jester P, Niranjan V, Rath B, Clinch B, Sánchez PJ,
Ampofo K, et al: The posology of oseltamivir in infants with
influenza infection using a population pharmacokinetic approach.
Clin Pharmacol Ther. 96:380–389. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rath B, von Kleist M, Tief F, Karsch K,
Tuerk E, Muehlhans S, Louis F, Skopnik H, Schweiger B and Duwe S:
Virus load kinetics and resistance development during oseltamivir
treatment in infants and children infected with Influenza A(H1N1)
2009 and Influenza B viruses. Pediatr Infect Dis J. 31:899–905.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rath B, Chen X, Spies V, Muehlhans S,
Obermeier P, Tief F, Seeber L, Karsch K, Milde J, Skopnik H, et al:
Prospective surveillance of antiviral resistance in hospitalized
infants less than 12 months of age with A(H3N2) influenza infection
and treated with oseltamivir. Antivir Ther. 22:515–522. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tief F, Hoppe C, Seeber L, Obermeier P,
Chen X, Karsch K, Mühlhans S, Adamou E, Conrad T, Beresniak A, et
al: An inception cohort study assessing the role of pneumococcal
and other bacterial pathogens in children with influenza and ILI
and a clinical decision model for stringent antibiotic use. Antivir
Ther. 21:413–424. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Seeber L, Michl B, Rundblad G, Trusko B,
Schnjakin M, Meinel C, Weinberg U, Gaedicke G and Rath B: A design
thinking approach to effective vaccine safety communication. Curr
Drug Saf. 10:31–40. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rath B: Vienna Vaccine Safety Initiative.
Hum Vaccin Immunother. 14:1038–1041. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Seeber L, Conrad T, Hoppe C, Obermeier P,
Chen X, Karsch K, Muehlhans S, Tief F, Boettcher S, Diedrich S, et
al: Educating parents about the vaccination status of their
children: A user-centered mobile application. Prev Med Rep.
5:241–250. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maurer W, Seeber L, Rundblad G, Kochhar S,
Trusko B, Kisler B, Kush R and Rath B; Vienna Vaccine Safety
Initiative, : Standardization and simplification of vaccination
records. Expert Rev Vaccines. 13:545–559. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rath B, Conrad T, Myles P, Alchikh M, Ma
X, Hoppe C, Tief F, Chen X, Obermeier P, Kisler B, et al: Influenza
and other respiratory viruses: Standardizing disease severity in
surveillance and clinical trials. Expert Rev Anti Infect Ther.
15:545–568. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Karsch K, Chen X, Miera O, Peters B,
Obermeier P, Francis RC, Amann V, Duwe S, Fraaij P, Heider A, et
al: Pharmacokinetics of Oral and Intravenous Oseltamivir Treatment
of Severe Influenza B Virus Infection Requiring Organ Replacement
Therapy. Eur J Drug Metab Pharmacokinet. 42:155–164. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rath B, Maltezou HC, Papaevangelou V,
Papagrigoriou-Theodoridou MA, Alchikh M, Myles P and Schweiger B;
PEDSIDEA Network, : Partnering for enhanced digital surveillance of
influenza-like disease and the effect of antivirals and vaccines
(PEDSIDEA). Influenza Other Respir Viruses. 13:309–318. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hoppe C, Obermeier P, Muehlhans S, Alchikh
M, Seeber L, Tief F, Karsch K, Chen X, Boettcher S, Diedrich S, et
al: Innovative Digital Tools and Surveillance Systems for the
Timely Detection of Adverse Events at the Point of Care: A
Proof-of-Concept Study. Drug Saf. 39:977–988. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Obermeier P, Muehlhans S, Hoppe C, Karsch
K, Tief F, Seeber L, Chen X, Conrad T, Boettcher S, Diedrich S, et
al: Enabling Precision Medicine With Digital Case Classification at
the Point-of-Care. EBioMedicine. 4:191–196. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Twilt M: Precision Medicine: The new era
in medicine. EBioMedicine. 4:24–25. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Muehlhans S, Richard G, Ali M, Codarini G,
Elemuwa C, Khamesipour A, Maurer W, Mworozi E, Kochhar S, Rundblad
G, et al: Safety reporting in developing country vaccine clinical
trials-a systematic review. Vaccine. 30:3255–3265. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Muehlhans S, von Kleist M, Gretchukha T,
Terhardt M, Fegeler U, Maurer W, Namazova-Baranova L, Gaedicke G,
Baranov A and Rath B: Awareness and utilization of reporting
pathways for adverse events following immunization: Online survey
among pediatricians in Russia and Germany. Paediatr Drugs.
16:321–330. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Karsch K, Obermeier P, Seeber L, Chen X,
Tief F, Mühlhans S, Hoppe C, Conrad T, Böttcher S, Diedrich S, et
al: Human Parechovirus Infections Associated with Seizures and Rash
in Infants and Toddlers. Pediatr Infect Dis J. 34:1049–1055. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Obermeier PE, Karsch K, Hoppe C, Seeber L,
Schneider J, Mühlhans S, Chen X, Tief F, Kaindl AM, Weschke B, et
al: Acute Disseminated Encephalomyelitis After Human Parechovirus
Infection. Pediatr Infect Dis J. 35:35–38. 2016.PubMed/NCBI
|
|
31
|
McWillimans P and McMillan S: Mobile tools
to detect AEs successfully used in Germany. React Wkly. 1609:92016.
View Article : Google Scholar
|
|
32
|
Myles P, Swenshon S, Haase K, Szeles T,
Jung C, Jacobi F and Rath B: A comparative analysis of
psychological trauma experienced by children and young adults in
two scenarios: Evacuation after a natural disaster vs forced
migration to escape armed conflict. Public Health. 158:163–175.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rath B, Swenshon S, Haase K, Szeles T,
Jung C, Jacobi F and Myles P: Using a mobile application to detect
health needs among children and adolescents who are newly arrived
migrants in Europe. J Public Health (Oxf). Nov 13–2018.(Epub ahead
of print). View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Esmaili BE: Caravans and Containers:
Children on the Move, Immobilized. Pediatrics. 142:e201814702018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
ISSOP Migration Working Group, : ISSOP
position statement on migrant child health. Child Care Health Dev.
44:161–170. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Schrier L, Wyder C, Del Torso S, Stiris T,
von Both U, Brandenberger J and Ritz N: Medical care for migrant
children in Europe: A practical recommendation for first and
follow-up appointments. Eur J Pediatr. Jun 26–2019.(Epub ahead of
print). View Article : Google Scholar
|
|
37
|
Elemuwa C, Kutalek R, Ali M, Mworozi E,
Kochhar S and Rath B; Vienna Vaccine Safety Initiative, : Global
lessons from Nigeria's ebolavirus control strategy. Expert Rev
Vaccines. 14:1397–1400. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kochhar S, Rath B, Seeber LD, Rundblad G,
Khamesipour A and Ali M; Vienna Vaccine Safety Initiative, :
Introducing new vaccines in developing countries. Expert Rev
Vaccines. 12:1465–1478. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rath B, Martus P and Wiesemann C:
‘Hippocrates is dead, long live Hippocrates?’ Medical Students'
Perceptions of the Hippocratic Oath, an Investigation at Athens
UniversityFirst World Congress on Codes in Ethics in Medicine.
Freiburg: 1997
|
|
40
|
Gesundheit B and Hadad E: Maimonides
(1138-1204): Rabbi, physician and philosopher. Isr Med Assoc J.
7:547–553. 2005.PubMed/NCBI
|
|
41
|
Marriott IA: The Geneva Convention:
humanitarian law and medicine. Can Med Assoc J. 118:565–566,
571-572, 593. 1978.PubMed/NCBI
|
|
42
|
Pellegrino ED: Medical ethics: Entering
the post-Hippocratic era. J Am Board Fam Pract. 1:230–237.
1988.PubMed/NCBI
|
|
43
|
Nirta L and Roh H: Cultural diversity
should be taught: a reply to UK medical students' view on
interacting with multicultural patients. Korean J Med Educ. 31:176.
2019. View Article : Google Scholar
|
|
44
|
Sieghart P: Professions as the conscience
of society. J Med Ethics. 11:117–122. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wiesing U: The Hippocratic Oath and the
Declaration of Geneva: Legitimisation attempts of professional
conduct. Med Health Care Philos. 1–6. 2019.PubMed/NCBI
|
|
46
|
Murphy P: Are patients' decisions to
refuse treatment binding on health care professionals? Bioethics.
19:189–201. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jansen LA and Wall S: Reconsidering
paternalism in clinical research. Bioethics. 32:50–58. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Morley J and Floridi L: The Limits of
Empowerment: How to Reframe the Role of mHealth Tools in the
Healthcare Ecosystem. Sci Eng Ethics. Jun 6–2019.(Epub ahead of
print). View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wachter RM, Judson TJ and Mourad M:
Reimagining Specialty Consultation in the Digital Age: The
Potential Role of Targeted Automatic Electronic Consultations.
JAMA. Jun 27–2019.(Epub ahead of print). View Article : Google Scholar
|
|
50
|
No authors listed. Medicine in the digital
age. Nat Med. 25:12019. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Fullerton Z: The Protection of Individual
Inviolability: Nazi Doctors and their Mark on Biomedical Research.
SeniorCapstone Projects, Paper 402, 2015. https://digitalwindow.vassar.edu/cgi/viewcontent.cgi?article=1399&context=senior_capstoneJune
20–2019
|
|
52
|
Lemaire F: The 60th anniversary of the
Nuremberg doctor's trial: Why a so long waiting to implement the
Code? Med Sci (Paris). 23:1063–1067. 2007.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Mitscherlich A and Mielke F: Medizin ohne
Menschlichkeit: Dokumente des Nürnberger Ärzteprozesses: FISCHER
Taschenbuch. 1989.
|
|
54
|
Proctor RN: Racial hygieneMedicine under
the Nazis. Harvard University Press; Cambridge, MA: 1988
|
|
55
|
Reis SP, Wald HS and Weindling P: The
Holocaust, medicine and becoming a physician: The crucial role of
education. Isr J Health Policy Res. 8:552019. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Page K: The four principles: Can they be
measured and do they predict ethical decision making? BMC Med
Ethics. 13:102012. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Garattini C, Raffle J, Aisyah DN, Sartain
F and Kozlakidis Z: Big Data Analytics, Infectious Diseases and
Associated Ethical Impacts. Philos Technol. 32:69–85. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Rath BA, Olshen RA, Halpern J and Merigan
TC: Persistence versus reversion of 3TC resistance in HIV-1
determine the rate of emergence of NVP resistance. Viruses.
4:1212–1234. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Rath BA, von Kleist M, Castillo ME,
Kolevic L, Caballero P, Soto-Castellares G, Amedee AM, Robinson JE,
Katzenstein DK, Van Dyke RB, et al: Antiviral resistance and
correlates of virologic failure in the first cohort of HIV-infected
children gaining access to structured antiretroviral therapy in
Lima, Peru: A cross-sectional analysis. BMC Infect Dis. 13:12013.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Rath BA, Yousef KP, Katzenstein DK, Shafer
RW, Schütte C, von Kleist M and Merigan TC: In vitro HIV-1
evolution in response to triple reverse transcriptase inhibitors
& in silico phenotypic analysis. PLoS One. 8:e611022013.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Mammas IN, Greenough A, Theodoridou M and
Spandidos DA: Paediatric Virology: A new paediatric subspecialty? A
proposal at the Workshop on Paediatric Virology, Athens, October
10, 2015. Exp Ther Med. 11:3–5. 2016. View Article : Google Scholar : PubMed/NCBI
|
